Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $36.75B | $33.42B | +9.95% |
Cost of Revenue | $12.04B | $12.86B | -6.39% |
Operating Income | $9.08B | $7.26B | +25.10% |
Net Income | $7.71B | $4.09B | +88.53% |
EPS (Basic) | $14.33 | $7.62 | +88.06% |
EPS (Diluted) | $14.23 | $7.56 | +88.23% |
SG&A Expense | $7.05B | $7.1B | -0.65% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $90.59B | $91.84B | -1.36% |
Current Assets | $29.06B | $29.03B | +0.09% |
Current Liabilities | $25.49B | $23.1B | +10.35% |
Stockholders' Equity | $8.66B | $5.88B | +47.32% |
Cash & Equivalents | $9.13B | $11.97B | -23.75% |
Long-Term Debt | $54.6B | $60.1B | -9.14% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $9.96B | $11.49B | -13.33% |
Investing Cash Flow | $-1.94B | $-1.05B | -85.76% |
Financing Cash Flow | $-10.86B | $-9.41B | -15.34% |
Share Buybacks | $0 | $200M | -100.00% |
D&A | $5.17B | $5.59B | -7.60% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 24.7% | 21.7% | +2.99% |
Net Margin | 21.0% | — | — |
ROE | 89.1% | — | — |
ROA | 8.5% | — | — |
Current Ratio | $1.14 | — | — |
Other companies in Biotechnology